BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38073992)

  • 1. Superficial CD34-Positive Fibroblastic Tumor: A Case Series and a Review of Literature.
    Zafar G; Nasir S; Zaman S
    Cureus; 2023 Nov; 15(11):e48504. PubMed ID: 38073992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superficial CD34-Positive Fibroblastic Tumor: A Newly Recognized Entity With Overlapping Features of PRDM10-Rearranged Soft Tissue Tumors.
    Shaker N; Abu Shakra R; Sangueza OP
    Cureus; 2023 Oct; 15(10):e47831. PubMed ID: 38021590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superficial CD34-Positive Fibroblastic Tumor: Two Case Reports.
    Yim JE; Kwon HM; Kim HR; Shin DH; Choi JS; Choi JH; Bae YK
    Ann Dermatol; 2023 May; 35(Suppl 1):S25-S29. PubMed ID: 37853859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superficial CD34-positive fibroblastic tumor (SCPFT): A review of pathological and clinical features.
    Salah HT; D'ardis JA; Baek D; Schwartz MR; Ayala AG; Ro JY
    Ann Diagn Pathol; 2022 Jun; 58():151937. PubMed ID: 35344860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superficial CD34-positive fibroblastic tumor: A new entity; case report and review of literature.
    Sood N; Khandelia BK
    Indian J Pathol Microbiol; 2017; 60(3):377-380. PubMed ID: 28937375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superficial CD34-positive fibroblastic tumor: report of 18 cases of a distinctive low-grade mesenchymal neoplasm of intermediate (borderline) malignancy.
    Carter JM; Weiss SW; Linos K; DiCaudo DJ; Folpe AL
    Mod Pathol; 2014 Feb; 27(2):294-302. PubMed ID: 23887307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superficial CD34-positive fibroblastic tumor: report of two cases and review of literature.
    Mao X; Sun YY; Deng ML; Ma T; Yu L
    Int J Clin Exp Pathol; 2020; 13(1):38-43. PubMed ID: 32055270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superficial CD34 positive fibroblastic tumor: report of three cases and review of the literature.
    Batur S; Ozcan K; Ozcan G; Tosun I; Comunoglu N
    Int J Dermatol; 2019 Apr; 58(4):416-422. PubMed ID: 30569527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case of recurrent superficial CD34-positive fibroblastic tumor.
    Salah HT; D'Ardis JA; Baek D; Duran J; Schwartz MR; Ayala AG; Ro JY
    J Cutan Pathol; 2023 Jun; 50(6):477-480. PubMed ID: 36107756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superficial CD34-positive fibroblastic tumor in the forearm of a middle-aged patient: A newly described, rare soft-tissue tumor.
    Rekhi B; Banerjee D; Gala K; Gulia A
    Indian J Pathol Microbiol; 2018; 61(3):421-424. PubMed ID: 30004071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superficial CD34-positive fibroblastic tumour: a clinicopathological and immunohistochemical study of an additional series.
    Lao IW; Yu L; Wang J
    Histopathology; 2017 Feb; 70(3):394-401. PubMed ID: 27636918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superficial CD34-Positive Fibroblastic Tumor on the Chest Wall of an 8-Year-Old Girl: A Case Report and Literature Review.
    Li SY; Zhang HL; Bai YZ
    Pediatr Hematol Oncol; 2021 Sep; 38(6):602-608. PubMed ID: 33792506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superficial CD34-positive fibroblastic tumor: Cytologic features, tissue correlation, ancillary studies, and differential diagnosis of a recently described soft tissue neoplasm.
    Li W; Molnar SL; Mott M; White E; De Las Casas LE
    Diagn Cytopathol; 2016 Nov; 44(11):926-930. PubMed ID: 27432164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine needle aspiration cytology of a superficial CD34-positive fibroblastic tumour, including differential diagnoses and recent updates.
    Rekhi B
    Cytopathology; 2023 Jan; 34(1):66-71. PubMed ID: 36151940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superficial CD34-positive fibroblastic tumor: A new case from Japan.
    Wada N; Ito T; Uchi H; Nakahara T; Tsuji G; Yamada Y; Oda Y; Furue M
    J Dermatol; 2016 Aug; 43(8):934-6. PubMed ID: 26946226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological features of superficial CD34-positive fibroblastic tumor.
    Ding L; Xu WJ; Tao XY; Zhang L; Cai ZG
    World J Clin Cases; 2021 Apr; 9(12):2739-2750. PubMed ID: 33969057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superficial CD34-Positive Fibroblastic Tumor: Report of an Extremely Rare Entity.
    Zemheri E; Karadag AS; Yılmaz İ
    Indian J Dermatol; 2020; 65(6):526-529. PubMed ID: 33487713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblastic connective tissue nevus: a rare cutaneous lesion analyzed in a series of 25 cases.
    de Feraudy S; Fletcher CD
    Am J Surg Pathol; 2012 Oct; 36(10):1509-15. PubMed ID: 22892597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases.
    Perret R; Michal M; Carr RA; Velasco V; Švajdler M; Karanian M; Meurgey A; Paindavoine S; Soubeyran I; Coindre JM; Boidot R; Charon-Barra C; Geneste D; Weingertner N; Pissaloux D; Tirode F; Baud J; Le Loarer F
    Histopathology; 2021 Nov; 79(5):810-825. PubMed ID: 34121219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acral myxoinflammatory fibroblastic sarcoma: a low-grade tumor of the hands and feet.
    Meis-Kindblom JM; Kindblom LG
    Am J Surg Pathol; 1998 Aug; 22(8):911-24. PubMed ID: 9706971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.